Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Anticoagulation - oral - Management
How is anticoagulation treatment initiated?

  • Anticoagulants are usually initiated in secondary care, a dedicated clinic in a hospital, or an outreach clinic in primary care.
  • Where rapid anticoagulation is required:
    • Warfarin is usually started with a loading dose of 10 mg.
    • Subsequent doses depend up the prothrombin time reported as international normalized ratio (INR).
    • For people older than 60 years of age, those with liver disease or cardiac failure, or those at high risk of bleeding, regimens that start with warfarin 5 mg doses, or a single 10 mg dose followed by 5 mg doses, may be preferable.
    • It takes 48 to 72 hours for the anticoagulant effect of warfarin to fully develop.
    • If an immediate effect is required (for example deep venous thrombosis or a pulmonary embolism) heparin is given concomitantly. This is done in secondary care.
  • For people with with atrial fibrillation:
    • There is no need to achieve anticoagulation rapidly; a slow loading regimen is safe and achieves therapeutic coagulation in the majority of people within 3–4 weeks.
      • Warfarin 2 or 3 mg each day is generally an acceptable starting dose.
      • A low starting dose is often more suitable for elderly people and people at high risk of bleeding.

© NHS Institute for Innovation and Improvement